The economics of alternative payment models for pharmaceuticals
| Year of publication: |
2021
|
|---|---|
| Authors: | Hlávka, Jakub P. ; Yu, Jeffrey C. ; Goldman, Dana P. ; Lakdawalla, Darius |
| Published in: |
The European journal of health economics. - Berlin : Springer, ISSN 1618-7601, ZDB-ID 2011428-X. - Vol. 22.2021, 4, p. 559-569
|
| Subject: | Optimal Pricing | Price Discrimination | Pharmacoeconomics | Health Insurance | Health Care Financing | Deadweight Loss | Arzneimittel | Pharmaceuticals | Gesundheitsfinanzierung | Health care financing | Theorie | Theory | Preisdifferenzierung | Price discrimination | Krankenversicherung | Health insurance | Gesundheitsökonomik | Health economics | Preismanagement | Pricing strategy | Arzneimittelmarkt | Pharmaceutical market | Gesetzliche Krankenversicherung | Public health insurance | Pharmaindustrie | Pharmaceutical industry | Gesundheitskosten | Health care costs |
-
Paying for pharmaceuticals : uniform pricing versus two-part tariffs
Brekke, Kurt R., (2022)
-
Pricing the pharmaceuticals when the ability to pay differs
Kanniainen, Vesa, (2021)
-
Sustainability of pharmaceutical expenditures in the German social health care system
Hammerschmidt, Thomas, (2022)
- More ...
-
Predicting quantity and quality of life with the Future Elderly Model
Ermini Leaf, Duncan, (2020)
-
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes?
Myerson, Rebecca Mary, (2019)
-
International Differences in Longevity and Health and Their Economic Consequences
Michaud, Pierre-Carl, (2010)
- More ...